Edwards Lifesciences

By person

27 insiders · 981 transactions

7.9×

Mr. Zovighian holds 7.9 times base salary in stock. $9.43M of shares against $1.19M in salary for 2025.

Salary from the company's own proxy. The shares are what Mr. Zovighian last reported holding, valued at $87.51, the price Common Stock was last bought or sold at on the open market here, on 11 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

MUSSALLEM MICHAEL A

Director

—

$363.37M (296) scheduled

−$363.37M

4,042,863

0.7014%

$353.79M

+36.1%

BOBO DONALD E JR

CVP,Strategy/Corp Development

—

$118.50M (186) scheduled

−$118.50M

121,409

0.0211%

$10.62M

−40.0%

Ullem Scott B.

CVP, Chief Financial Officer

—

$75.91M (69) scheduled

−$75.91M

313,058

0.0543%

$27.40M

+20.8%

Wood Larry L

Global President TAVR & Surg

—

$75.28M (97) scheduled

−$75.28M

207,066

0.0359%

$18.12M

+22.1%

WANG HUIMIN

CVP, Japan & Intercontinental

—

$48.54M (81) scheduled

−$48.54M

99,381

0.0172%

$8.70M

−29.1%

Szyman Catherine M.

CVP, Critical Care

$1.07M (2)

$43.22M (84) scheduled

−$42.15M

81,287

0.0141%

$7.11M

+51.7%

Lemercier Jean-Luc M

CVP, EMEACLA and JAPAC

—

$22.66M (30) scheduled

−$22.66M

184,686

0.0320%

$16.16M

+38.7%

Zovighian Bernard J

CEO

$49.75K (1)

$14.21M (18) scheduled

−$14.16M

107,761

0.0187%

$9.43M

+252.5%

SELLERS ROBERT W.A.

SVP, Corporate Controller

—

$13.66M (18) scheduled

−$13.66M

37,490

0.0065%

$3.28M

−19.7%

Chopra Daveen

CVP, TMTT, Surgical & IHFM

—

$11.08M (24) scheduled

−$11.08M

43,926

0.0076%

$3.84M

+368.9%

Verguet Patrick B

CVP, Europe

—

$9.87M (11) scheduled

−$9.87M

129,137

0.0224%

$11.30M

0.0%

LINK WILLIAM J PHD

Director

—

$7.03M (8)

−$7.03M

16,071

0.0028%

$1.41M

−72.7%

GALLAHUE KIERAN

Director

$524.20K (2)

$3.84M (2) scheduled

−$3.32M

71,534

0.0124%

$6.26M

+131.0%

Marsh Martha H.

Director

—

$3.10M (1) scheduled

−$3.10M

31,880

0.0055%

$2.79M

+76.6%

STONE HEISZ LESLIE

Director

—

$2.92M (6) scheduled

−$2.92M

34,199

0.0059%

$2.99M

+166.2%

Lippis Daniel J.

CVP, TAVR

—

$1.93M (25) scheduled

−$1.93M

40,034

0.0069%

$3.50M

+116.4%

Markowitz Wayne

CVP, JAPAC

—

$1.11M (7) scheduled

−$1.11M

19,371

0.0034%

$1.70M

+8,591%

VON SCHACK WESLEY W

Director

—

$968.25K (4)

−$968.25K

9,737

0.0017%

$852.08K

−7.8%

VALERIANI NICHOLAS J

Director

$168.35K (1)

$698.75K (1) scheduled

−$530.41K

84,423

0.0146%

$7.39M

+140.0%

LORANGER STEVEN R

Director

—

$438.58K (1) scheduled

−$438.58K

8,997

0.0016%

$787.33K

—

Bruls Annette

CVP, EMEACLA

—

$237.91K (1)

−$237.91K

17,984

0.0031%

$1.57M

+122.6%

Dahl Andrew M.

SVP, Corporate Controller

—

$98.39K (2)

−$98.39K

14,615

0.0025%

$1.28M

+493.4%

Mistras Theodora

CVP, Chief Financial Officer

—

99,920

0.0173%

$8.74M

—

LAVIOLETTE PAUL A

Director

—

17,552

0.0030%

$1.54M

—

Davis Leslie C.

Director

—

9,834

0.0017%

$860.57K

—

Feinberg David T

Director

—

9,087

0.0016%

$795.20K

—

Sequeira Ramona

Director

—

6,779

0.0012%

$593.23K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Dahl Andrew M.

31 Aug 2026

SVP, Corporate Controller

Sell

544

$91.06

$49.53K

Bruls Annette

28 Aug 2026

CVP, EMEACLA

Sell

2,644

$89.98

$237.91K

Markowitz Wayne

26 Aug 2026

CVP, JAPAC

Sell

1,240

$91.47

$113.42K

Markowitz Wayne

30 Jul 2026

CVP, JAPAC

Sell

146

$86.03

$12.59K

Zovighian Bernard J

27 Jul 2026

CEO

Sell indirect

2,921

$83.93

$245.13K

Dahl Andrew M.

29 May 2026

SVP, Corporate Controller

Sell

568

$86.08

$48.85K

BOBO DONALD E JR

27 May 2026

CVP,Strategy/Corp Development

Sell indirect

23,145

$86.42

$2.00M

Chopra Daveen

22 May 2026

CVP, TMTT & Surgical

Sell

1,500

$84.60

$126.91K

BOBO DONALD E JR

15 May 2026

CVP,Strategy/Corp Development

Sell indirect

8,000

$81.82

$654.57K

BOBO DONALD E JR

15 May 2026

CVP,Strategy/Corp Development

Sell

9,968

$82.07

$818.11K

Markowitz Wayne

11 May 2026

CVP, JAPAC

Sell

593

$79.73

$47.28K

BOBO DONALD E JR

25 Feb 2026

CVP,Strategy/Corp Development

Sell

24,000

$83.84

$2.01M

STONE HEISZ LESLIE

12 Dec 2025

Director

Sell

2,615

$83.41

$218.12K

BOBO DONALD E JR

12 Dec 2025

CVP,Strategy/Corp Development

Sell

5,900

$83.74

$494.07K

BOBO DONALD E JR

12 Dec 2025

CVP,Strategy/Corp Development

Sell

5,486

$83.79

$459.68K

Chopra Daveen

11 Dec 2025

CVP, TMTT & Surgical

Sell

2,000

$84.38

$168.75K

Markowitz Wayne

8 Dec 2025

CVP, JAPAC

Sell

583

$86.01

$50.14K

Chopra Daveen

25 Aug 2025

CVP, TMTT

Sell

2,500

$81.95

$204.87K

Lippis Daniel J.

28 Jul 2025

CVP, JAPAC

Sell

4,114

$79.46

$326.90K

Chopra Daveen

22 May 2025

CVP, TMTT

Sell

1,500

$75.08

$112.61K

Markowitz Wayne

7 May 2025

GM & SVP, Surgical

Sell

268

$75.08

$20.12K

Markowitz Wayne

6 Dec 2024

GM & SVP, Surgical

Sell

583

$73.27

$42.72K

Chopra Daveen

6 Dec 2024

CVP, TMTT

Sell

1,750

$73.27

$128.22K

Chopra Daveen

20 Aug 2024

CVP, TMTT

Sell

1,250

$69.95

$87.44K

Chopra Daveen

29 Aug 2023

CVP, TMTT

Sell

1,500

$76.69

$115.04K

STONE HEISZ LESLIE

10 Aug 2023

Director

Sell

3,303

$78.87

$260.51K

BOBO DONALD E JR

5 May 2023

CVP,Strategy/Corp Development

Sell

5,635

$88.63

$499.40K

Showing 250 of 981 transactions. The figures above use every one of them.

By person

Individual transactions

What was left out